Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 118

Similar articles for PubMed (Select 24074702)

1.

Who are at risk for thromboembolism after arthroplasty? A systematic review and meta-analysis.

Zhou X, Qian W, Li J, Zhang P, Yang Z, Chen W, Wu L.

Thromb Res. 2013 Nov;132(5):531-6. doi: 10.1016/j.thromres.2013.09.005. Epub 2013 Sep 13. Review.

PMID:
24074702
2.

Genetic polymorphisms in venous thrombosis and pulmonary embolism after total hip arthroplasty: a pilot study.

Ringwald J, Berger A, Adler W, Kraus C, Pitto RP.

Clin Orthop Relat Res. 2009 Jun;467(6):1507-15. doi: 10.1007/s11999-008-0498-7. Epub 2008 Sep 18.

3.

The genetics of venous thromboembolism. A meta-analysis involving approximately 120,000 cases and 180,000 controls.

Gohil R, Peck G, Sharma P.

Thromb Haemost. 2009 Aug;102(2):360-70. doi: 10.1160/TH09-01-0013.

PMID:
19652888
4.

A case control study on the contribution of factor V-Leiden, prothrombin G20210A, and MTHFR C677T mutations to the genetic susceptibility of deep venous thrombosis.

Almawi WY, Tamim H, Kreidy R, Timson G, Rahal E, Nabulsi M, Finan RR, Irani-Hakime N.

J Thromb Thrombolysis. 2005 Jun;19(3):189-96.

PMID:
16082606
5.

Factor V Leiden (G1691A) and prothrombin gene G20210A mutations as potential risk factors for venous thromboembolism after total hip or total knee replacement surgery.

Wåhlander K, Larson G, Lindahl TL, Andersson C, Frison L, Gustafsson D, Bylock A, Eriksson BI.

Thromb Haemost. 2002 Apr;87(4):580-5.

PMID:
12008938
6.

Single and combined prothrombotic factors in patients with idiopathic venous thromboembolism: prevalence and risk assessment.

Salomon O, Steinberg DM, Zivelin A, Gitel S, Dardik R, Rosenberg N, Berliner S, Inbal A, Many A, Lubetsky A, Varon D, Martinowitz U, Seligsohn U.

Arterioscler Thromb Vasc Biol. 1999 Mar;19(3):511-8.

7.

Prothrombin and factor V mutations in women with a history of thrombosis during pregnancy and the puerperium.

Gerhardt A, Scharf RE, Beckmann MW, Struve S, Bender HG, Pillny M, Sandmann W, Zotz RB.

N Engl J Med. 2000 Feb 10;342(6):374-80.

8.

Deletion polymorphism in the angiotensin-converting enzyme gene as a thrombophilic risk factor after hip arthroplasty.

Philipp CS, Dilley A, Saidi P, Evatt B, Austin H, Zawadsky J, Harwood D, Ellingsen D, Barnhart E, Phillips DJ, Hooper WC.

Thromb Haemost. 1998 Dec;80(6):869-73.

PMID:
9869151
9.

Factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations are not associated with chronic limb ischemia: the Linz Peripheral Arterial Disease (LIPAD) study.

Mueller T, Marschon R, Dieplinger B, Haidinger D, Gegenhuber A, Poelz W, Webersinke G, Haltmayer M.

J Vasc Surg. 2005 May;41(5):808-15.

PMID:
15886665
10.

Genetic polymorphisms associated with acute pulmonary embolism and deep venous thrombosis.

Nizankowska-Mogilnicka E, Adamek L, Grzanka P, Domagala TB, Sanak M, Krzanowski M, Szczeklik A.

Eur Respir J. 2003 Jan;21(1):25-30.

11.

Risk of venous thromboembolism associated with single and combined effects of Factor V Leiden, Prothrombin 20210A and Methylenetethraydrofolate reductase C677T: a meta-analysis involving over 11,000 cases and 21,000 controls.

Simone B, De Stefano V, Leoncini E, Zacho J, Martinelli I, Emmerich J, Rossi E, Folsom AR, Almawi WY, Scarabin PY, den Heijer M, Cushman M, Penco S, Vaya A, Angchaisuksiri P, Okumus G, Gemmati D, Cima S, Akar N, Oguzulgen KI, Ducros V, Lichy C, Fernandez-Miranda C, Szczeklik A, Nieto JA, Torres JD, Le Cam-Duchez V, Ivanov P, Cantu-Brito C, Shmeleva VM, Stegnar M, Ogunyemi D, Eid SS, Nicolotti N, De Feo E, Ricciardi W, Boccia S.

Eur J Epidemiol. 2013 Aug;28(8):621-47. doi: 10.1007/s10654-013-9825-8. Epub 2013 Jul 31.

12.

Genetic susceptibility to pregnancy-related venous thromboembolism: roles of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations.

Grandone E, Margaglione M, Colaizzo D, D'Andrea G, Cappucci G, Brancaccio V, Di Minno G.

Am J Obstet Gynecol. 1998 Nov;179(5):1324-8.

PMID:
9822524
13.
14.

Combined genetic mutations have remarkable effect on deep venous thrombosis and/or pulmonary embolism occurence.

Simsek E, Yesilyurt A, Pinarli F, Eyerci N, Ulus AT.

Gene. 2014 Feb 15;536(1):171-6. doi: 10.1016/j.gene.2013.11.019. Epub 2013 Dec 12.

PMID:
24334115
15.
16.

Genetic mutations in Turkish population with pulmonary embolism and deep venous thrombosis.

Kupeli E, Verdi H, Simsek A, Atac FB, Eyuboglu FO.

Clin Appl Thromb Hemost. 2011 Nov-Dec;17(6):E87-94. doi: 10.1177/1076029610385224. Epub 2010 Nov 15.

PMID:
21078611
18.
19.

PLA2 polymorphism of platelet glycoprotein IIb/IIIa but not Factor V Leiden and prothrombin G20210A polymorphisms is associated with venous thromboembolism and more recurrent events in central Iran.

Pourgheysari B, Boroujeni HR, Hasheminia AM, Drees F.

Blood Coagul Fibrinolysis. 2013 Jul;24(5):471-6. doi: 10.1097/MBC.0b013e32835e4260.

PMID:
23358226
20.

Prevalence of factor V Leiden, FII G20210A, FXIII Val34Leu and MTHFR C677T polymorphisms in cancer patients with and without venous thrombosis.

Ramacciotti E, Wolosker N, Puech-Leao P, Zeratti EA, Gusson PR, del Giglio A, Franco RF.

Thromb Res. 2003 Feb 15;109(4):171-4.

PMID:
12757770
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk